Skinvisible Inc

skinvisible.com

What Do They Do?

Develops and licenses patented topical skin products and a polymer delivery system to pharmaceutical and consumer goods companies.

How Do They Make Money?

Pharmaceutical and consumer goods companies pay an upfront fee and ongoing royalties for licensed topical products; buyers of Invisicare polymers pay for products sold and delivered.

FY2025 revenue

Who Are Their Customers?

Licenses products to pharmaceutical and consumer goods companies around the world, including established manufacturers and marketers of brands.

Do Revenues Turn Into Profits?

No. It lost $1.1M in FY2025.

Operating income, FY2025

−2482% of revenue

▼ −16% (Loss) vs FY2024 (−$589.6K, −2948%)

Net income, FY2025

−5320% of revenue

▲ +88% (Loss) vs FY2024 (−$565.7K, −2828%)

Free cash flow, FY2025

−212% of revenue

▼ −46% (Loss) vs FY2024 (−$79.1K, −395%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▲ 0%; vs $5K in Q2 FY2025
Net income: ▼ −7% (Loss); vs −$274.4K in Q2 FY2025

Shrinking. Revenue fell 97% in 4 years, from $663.4K in FY2021 to $20K in FY2025, about 58% a year.

Transdermal product development The latest report adds work on transdermal formulations for obesity and glucose control and says the company is pursuing pharmaceutical and biotech partners; the older overview focused on topical skin products and licensing.

Comments